USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore

NEW DELHI: Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal valued at more than Rs.... Read more »